Collecting and analyzing sputum samples for lung cancer detection
Official title: Collection of Sputum and Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer
Run by bioAffinity Technologies Inc. · NCT03457415 · Data updated 2026-11-12
This study is testing if analyzing sputum samples can help detect lung cancer better than current methods in healthy people, those at high risk, and patients already diagnosed with lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | bioAffinity Technologies Inc. Industry-sponsored |
| Locations | 3 sites (Summit, New Jersey and 2 other locations) |
| Status | Recruiting |
| Started | March 1, 2018 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | April 1, 2025 |
| Trial ID | NCT03457415 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 21 and older who fit into one of the three cohorts: healthy, high-risk smokers, or diagnosed lung cancer patients.
✕Probably not a fit
Patients who are not within the specified age range or do not meet the cohort criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to compare assay results from sputum samples to current lung cancer detection standards. It involves three cohorts: healthy participants, high-risk individuals, and diagnosed lung cancer patients. Participants in the high-risk group will undergo low-dose computed tomography (LDCT) scans to confirm their lung health before providing sputum samples. The samples will be processed to identify cell populations and detect cancerous cells using a specialized fluorescent compound.
Why it matters
Potential benefit: If successful, this study could enhance early detection of lung cancer, potentially leading to better patient outcomes.
How similar studies have gone: Other studies have shown promise in using sputum analysis for lung cancer detection, suggesting this approach may be viable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Each subject must meet the following criteria to be enrolled in this study: * Male or female * 21 years of age or older * Willing to provide primary care physician contact information to the investigator and agree to have medical information released if indicated * Meet requirements of one of three cohorts in the study: Healthy Cohort: Current non-smoker who has smoked less than 5 pack-years in his or her lifetime, and if smoked, quit more than 15 years ago, and has no known lung disease. High Risk Cohort: Individual aged ≥55-74 who is a current smoker with a smoking history of at least 30 pack-years, or current non-smoker who has a smoking history of at least 30 pack-years, and quit smoking within the past 15 years. Cancer Cohort: Individual who has been diagnosed by a physician as highly suspect for having lung cancer but has not yet undergone a biopsy nor received therapy, and after providing a sputum sample is confirmed to have lung cancer by biopsy. Exclusion Criteria: Participants who meet any of the following criteria will be excluded from the study: * Severe obstructive lung disease and unable to cough with sufficient exertion to produce a sputum sample. Participants with lung disease that are able to cough with sufficient exertion to produce a sputum sample are not excluded from the study * Angina with minimal exertion * Pregnancy
Where it's running
-
Atlantic Respiratory Institute
Summit, New Jersey, United States Recruiting -
Radiology Associates of Albuquerque
Albuquerque, New Mexico, United States Recruiting -
South Texas Veterans Health Care System (STVHCS)/Audie L. Murphy Memorial Veterans Hospital
San Antonio, Texas, United States Recruiting
Study contacts
- Study coordinator: Maria Zannes, JD
- Email: mz@bioaffinitytech.com
- Phone: 505-400-9747
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.